Literature DB >> 30232572

Peptidoglycan in Mycobacteria: chemistry, biology and intervention.

Tripti Raghavendra1, Saniya Patil1, Raju Mukherjee2.   

Abstract

Peptidoglycan, a major glycoconjugate in the mycobacterial cell envelope provides strength to resist osmotic stress and plays a pivotal role in maintaining the cellular morphology. Several unique growth stage specific structural alterations occur in its constituent monosaccharides and peptides that allow Mycobacterium to survive nutrient starvation and environmental stress. Here, we discuss the enzymes involved in its intricate biosynthesis that are novel targets for therapeutic intervention and provide an opportunity for potential antibiotic adjuvants. We also revisit the enzymatic steps which are critical for maintaining the equilibrium between peptidoglycan synthesis and hydrolysis during cellular growth and division specifically focused on the importance of cell wall remodelling during "exit from dormancy" in Mycobacterium, a phenomenon with tremendous physiological and therapeutic importance for intervention in mycobacterial infections.

Entities:  

Keywords:  Biosynthesis; Cell envelope; Peptidoglycan; Remodeling; Tuberculosis

Mesh:

Substances:

Year:  2018        PMID: 30232572     DOI: 10.1007/s10719-018-9842-7

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  117 in total

1.  The serine/threonine kinase PknB of Mycobacterium tuberculosis phosphorylates PBPA, a penicillin-binding protein required for cell division.

Authors:  Arunava Dasgupta; Pratik Datta; Manikuntala Kundu; Joyoti Basu
Journal:  Microbiology (Reading)       Date:  2006-02       Impact factor: 2.777

Review 2.  Advances in the development of new tuberculosis drugs and treatment regimens.

Authors:  Alimuddin Zumla; Payam Nahid; Stewart T Cole
Journal:  Nat Rev Drug Discov       Date:  2013-05       Impact factor: 84.694

Review 3.  Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?

Authors:  Robert C Goldman
Journal:  Tuberculosis (Edinb)       Date:  2013-09-18       Impact factor: 3.131

4.  Spatially distinct and metabolically active membrane domain in mycobacteria.

Authors:  Jennifer M Hayashi; Chu-Yuan Luo; Jacob A Mayfield; Tsungda Hsu; Takeshi Fukuda; Andrew L Walfield; Samantha R Giffen; John D Leszyk; Christina E Baer; Owen T Bennion; Ashoka Madduri; Scott A Shaffer; Bree B Aldridge; Christopher M Sassetti; Steven J Sandler; Taroh Kinoshita; D Branch Moody; Yasu S Morita
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

5.  Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.

Authors:  L J Piddock; K J Williams; V Ricci
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

6.  Recombinant expression and characterization of the major beta-lactamase of Mycobacterium tuberculosis.

Authors:  R K Voladri; D L Lakey; S H Hennigan; B E Menzies; K M Edwards; D S Kernodle
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

7.  Synthesis and biological evaluation of novel teixobactin analogues.

Authors:  Christian E Schumacher; Paul W R Harris; Xiao-Bo Ding; Bernard Krause; Tom H Wright; Gregory M Cook; Daniel P Furkert; Margaret A Brimble
Journal:  Org Biomol Chem       Date:  2017-10-25       Impact factor: 3.876

Review 8.  Resuscitation-promoting factors as lytic enzymes for bacterial growth and signaling.

Authors:  Bavesh Davandra Kana; Valerie Mizrahi
Journal:  FEMS Immunol Med Microbiol       Date:  2009-09-04

9.  Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors.

Authors:  Shajila Siricilla; Katsuhiko Mitachi; Bajoie Wan; Scott G Franzblau; Michio Kurosu
Journal:  J Antibiot (Tokyo)       Date:  2014-10-01       Impact factor: 2.649

10.  Visualization of mycobacterial membrane dynamics in live cells.

Authors:  Frances P Rodriguez-Rivera; Xiaoxue Zhou; Julie A Theriot; Carolyn R Bertozzi
Journal:  J Am Chem Soc       Date:  2017-02-23       Impact factor: 15.419

View more
  2 in total

1.  Arabinogalactan enhances Mycobacterium marinum virulence by suppressing host innate immune responses.

Authors:  Ye-Yu Li; Han-Mei Liu; Decheng Wang; Yan Lu; Cairong Ding; Li-Shuang Zhou; Xiang-Yang Wu; Zi-Wei Zhou; Shu-Qin Xu; Chen Lin; Lian-Hua Qin; Yao Li; Jun Liu; Hai-Peng Liu; Lu Zhang
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

2.  Breaking down walls.

Authors:  Moagi Tube Shaku; Bavesh Davandra Kana
Journal:  Elife       Date:  2018-10-24       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.